title: Hypotension and disseminated intravascular coagulation following intralesional bacillus Calmette-Guérin therapy for locally metastatic melanoma.
abstract: Four patients developed serious hypotension and signs of disseminated intravascular coagulation shortly after a second round of Tice bacillus Calmette-Guérin (BCG) injections into locally recurrent cutaneous melanoma satellite nodules. Each of these patients survived following intensive therapy with isoniazid, pyridoxine, steroids, pressors, antibiotics, and cardio-renal support including, in one case, three acute hemodialyses. Plasma specimens from two of the four patients caused gelation of lysate from the amebocytes of Limulus polyphemus, indicating the presence of endotoxin or an endotoxin-like substance. In vitro studies on the BCG preparations led us to conclude that this endotoxin activity in the plasma is not the result of direct injection of endotoxin with the BCG preparation, but rather from release of endotoxin from endogenous sources, such as the intestinal tract during a period of relative hypotension following an allergic reaction. Prior immunity appeared to be the consistent factor in the toxic reactions reported herein. Finally, we present recommendations for serial monitoring of these patients and discuss the use of an alternative agent for intralesional therapy.
authors.affiliation: George Washington University School of Medicine, Washington, D.C.
authors.forename: M H
authors.initials: MH
authors.lastname: Cohen
authors.forename: R J
authors.initials: RJ
authors.lastname: Elin
authors.forename: B J
authors.initials: BJ
authors.lastname: Cohen
mesh_terms: D000328:Adult; D001500:BCG Vaccine / Q000008:administration & dosage / Q000627:therapeutic use*; D004211:Disseminated Intravascular Coagulation / Q000209:etiology* / Q000628:therapy; D005260:Female; D006801:Humans; D007022:Hypotension / Q000209:etiology* / Q000628:therapy; D007167:Immunotherapy / Q000009:adverse effects; D015552:Injections, Intralesional; D008297:Male; D008545:Melanoma / Q000556:secondary / Q000628:therapy*; D008875:Middle Aged; D009846:Oliguria / Q000209:etiology / Q000628:therapy; D011654:Pulmonary Edema / Q000209:etiology / Q000628:therapy
chemical_list: D001500:BCG Vaccine